Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells.
Chen, Jichun
Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Apr 2007 - 4159-68 p. digital
Publication Type: Journal Article
0022-1767
10.4049/jimmunol.178.7.4159 doi
Anemia, Aplastic--drug therapy
Animals
Blood Cell Count
Bone Marrow--immunology
CD4 Antigens--analysis
CD8-Positive T-Lymphocytes--immunology
Cyclosporine--therapeutic use
Immunosuppression Therapy
Immunosuppressive Agents--therapeutic use
Interleukin-2 Receptor alpha Subunit--analysis
Lymphocyte Activation
Mice
Mice, Inbred C57BL
Minor Histocompatibility Antigens--immunology
Pancytopenia--drug therapy
T-Lymphocytes, Regulatory--transplantation
Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Apr 2007 - 4159-68 p. digital
Publication Type: Journal Article
0022-1767
10.4049/jimmunol.178.7.4159 doi
Anemia, Aplastic--drug therapy
Animals
Blood Cell Count
Bone Marrow--immunology
CD4 Antigens--analysis
CD8-Positive T-Lymphocytes--immunology
Cyclosporine--therapeutic use
Immunosuppression Therapy
Immunosuppressive Agents--therapeutic use
Interleukin-2 Receptor alpha Subunit--analysis
Lymphocyte Activation
Mice
Mice, Inbred C57BL
Minor Histocompatibility Antigens--immunology
Pancytopenia--drug therapy
T-Lymphocytes, Regulatory--transplantation